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transducer of endoplasmic reticulum stress
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Abstract
Excessive demands on the protein folding capacity of the endoplasmic reticulum (ER) cause 
irremediable ER stress and contribute to cell loss in a number of cell degenerative diseases, 
including type 2 diabetes and neurodegeneration1,2. The signals communicating catastrophic ER 
damage to the mitochondrial apoptotic machinery remain poorly understood3-6. We used a 
biochemical approach to purify a cytosolic activity induced by ER stress that causes release of 
cytochrome c from isolated mitochondria. We discovered that the principal component of the 
purified pro-apoptotic activity is proto-oncogene CT10-regulated kinase (CRK), an adaptor 
protein with no known catalytic activity7. Crk-/- cells are strongly resistant to ER stress-induced 
apoptosis. Moreover, CRK is cleaved in response to ER stress to generate an N-terminal ~14kD 
fragment with greatly enhanced cytotoxic potential. We identified a putative BCL2 homology-3 
(BH3) domain within this N-terminal CRK fragment, which sensitizes isolated mitochondria to 
cytochrome c release and when mutated significantly reduces CRK's apoptotic activity in vivo. 
Together these results identify CRK as a pro-apoptotic protein that signals irremediable ER stress 
to the mitochondrial execution machinery.
Irremediable ER stress represents a form of intrinsic cell damage that culminates in 
activation of the BAX/BAK-dependent mitochondrial apoptotic pathway3,4. Homo-
oligomerization of BAX and/or BAK consequently results in outer mitochondrial membrane 
permeabilization and release of pro-death mitochondrial proteins (e.g., cytochrome c) into 
the cytosol, causing activation of effector caspases8-10. For many forms of cell injury, 
including ER stress, we have a limited understanding of the cellular transducers that relay 
the information of upstream damage to BAX/BAK oligomerization at mitochondria. To 
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date, the only known BAX and/or BAK activators are members of the pro-apoptotic BH3-
only family, a diverse class of polypeptides containing a loosely conserved ~9-12 amino 
acid BH3 death domain11,12,13. The BH3-only proteins BID, BIM, NOXA and PUMA have 
been previously implicated in ER stress-induced death14,15; however, cells deficient in one 
or more of these proteins are not completely resistant to this form of apoptosis16-18. 
Therefore, it is highly probable that additional proteins that communicate ER stress to the 
mitochondrial apoptotic machinery remain to be discovered. To pursue this possibility, we 
took an unbiased biochemical approach to purify the major ER stress-induced cytosolic pro-
apoptotic activity.
Given their strong resistance to ER stress-induced apoptosis 16,17, we reasoned the 
Bax-/-Bak-/- mouse embryonic fibroblasts (MEFs) present a unique and powerful tool to trap 
and identify pre-mitochondrial apoptotic signals activated by ER stress. Therefore, we 
challenged SV40-transformed Bax-/-Bak-/- MEFs with the pharmacological agent Brefeldin 
A (BFA), which blocks ER-golgi protein transport, to induce irremediable ER stress and 
initiate the pre-mitochondrial apoptotic program. We prepared cytosolic extracts (S100) 
from untreated or BFA-treated Bax-/-Bak-/- MEFs, then incubated isolated Jurkat 
mitochondria with these extracts, and measured the amount of mitochondrial cytochrome c 
released as a readout for pro-apoptotic activity. The S100 of BFA-treated Bax-/-Bak-/- cells 
triggers the release of ~90% of total intra-mitochondrial cytochrome c in a BAX/BAK-
dependent manner15, while the S100 fraction from untreated Bax-/-Bak-/- MEFs induces 
negligible (<5%) cytochrome c release (Fig. 1a). Thus, ER stress induces a cytosolic activity 
capable of releasing mitochondrial cytochrome c, which we have termed Cytochrome c 
Releasing Activity (CcRA). We previously found that proteolytically active BID (tBID) is 
responsible for a portion of this CcRA (~30%), but that the majority of CcRA remains intact 
in BFA-treated Bid-/- S10015. Therefore, we designed and performed a biochemical 
purification strategy to isolate additional CcRA factors in the BFA-treated Bax-/-Bak-/- S100 
(Fig. 1b).
The CcRA-containing fractions from the final step (MonoQ gradient) (Fig. 1c) of the 
purification scheme did not contain detectable amounts of any known BH3-only protein by 
immunoblotting (data not shown), and so were analyzed by MALDI mass spectrometry (Fig. 
1c). Proto-oncogene CT10-regulated kinase (CRK) was the highest confidence protein 
identified by mass spectrometry in the active fractions, with approximately 25% of the total 
sequence represented in 6 tryptic peptides (Supplementary Table 1). C-crk encodes two 
splice isoforms, CRKI (28kD) and CRKII (38kD)7, which have been previously recognized 
as adaptor components in multi-protein complexes involved in cell morphology, movement, 
proliferation, and differentiation19. CRKI and CRKII share a common Src homology 2 
(SH2) domain and SH3 domain, while CRKII contains an additional C-terminal SH3 
domain (Fig. 1d)19. As the peptides detected by mass spectrometry are common to both 
CRKI and CRKII, this information did not differentiate which isoform is present in the 
analyzed fractions (Supplementary Table 1).
To test if CRK plays a role in ER stress-induced apoptosis in cells, we challenged crk-/- and 
wild-type (WT) matched MEFs with BFA or tunicamycin (TUN), an ER stress agent that 
specifically inhibits N-linked glycosylation. As previously reported, these crk-/- MEFs are 
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derived from genetically engineered embryos that fail to express either CRKI or CRKII20 
(Fig. 2a). Notably, S100 from BFA-treated crk-/- MEFs has significantly decreased CcRA 
compared to that from BFA-treated WT MEFs (Fig. 2b), indicating that CRK is required for 
the majority of the ER stress-induced apoptotic signal. In addition, crk-/- MEFs are strikingly 
resistant to ER stress-induced apoptosis, but as sensitive as WT MEFs to staurosporine 
(STS), a pan-kinase inhibitor known to activate the mitochondrial apoptotic pathway 
independently of ER stress, thereby confirming the pro-apoptotic role of CRK specifically in 
the ER stress-induced apoptotic pathway, rather than generally from other intrinsic stresses 
(Fig. 2c, d).
To investigate which CRK isoform is necessary for ER stress-induced apoptosis, we 
reconstituted crk-/- MEFs by transient transfection with expression constructs encoding 
either crkI or crkII and evaluated their sensitivity to ER stress-induced apoptosis. 
Surprisingly, crkI and crkII are both able to independently rescue the sensitivity of crk-/- 
MEFs to ER stress-induced apoptosis, arguing that a sequence common to CRKI and CRKII 
is required for CRK's apoptotic activity (Fig. 3a,b). We next attempted to use retroviral 
vectors to establish stable cells lines of crk-/- MEFs expressing either crkI or crkII. While we 
had no difficulty recovering cells reconstituted with crkII, all attempts to establish stable 
crkI expression in crk-/- MEFs were unsuccessful, indicating that CRKI may be inherently 
cytotoxic. Stable reconstitution of crkII in crk-/- MEFs restores sensitivity to ER stress 
agents, but does not affect the response to STS (Fig. 3c-e), recapitulating the transient 
expression results (Fig. 3a). Moreover, stable overexpression of crkII and transient 
overexpression of crkI further sensitizes WT MEFs to ER stress (Fig. 3f-i). Together, these 
data strongly argue that CRK is a critical component of the ER stress-induced apoptotic 
pathway.
To explore its potential role in ER stress, we monitored CRK mRNA and protein following 
BFA treatment (Supplementary Fig. S1). We detected no changes in CRKI or CRKII mRNA 
transcript levels upon ER stress (Supplementary Fig. S1). However, we found that ER stress 
causes depletion of full-length CRKII (Supplementary Fig. S2). To determine if CRKII is 
reduced in a specific subcellular compartment, we probed subcellular fractions from 
Bax-/-Bak-/- MEFs and found that CRKII is partially localized to the ER, mitochondria, and 
cytosol (Fig. 4a). Moreover, upon ER stress, 38kD ER- and cytosol- localized CRKII is 
reduced, while levels of the mitochondrion-localized full-length CRKII change very little 
(Fig. 4a). Interestingly, we found that upon ER stress, CRKII appears to be sequentially 
cleaved at least twice, resulting in several distinct fragments (Fig. 4a and Supplementary 
Fig. S3). Proteolytic cleavage is a post-translational modification recognized to activate 
other known pro-apoptotic proteins, such as BID, but had not been described previously for 
CRK21-24.
We tested if CRKI also undergoes cleavage events upon ER stress. Following ER stress, at 
least one CRKI-specific cleavage product is readily observed (Fig. 4b). In addition, we 
observe depletion of full-length endogenous CRKI and CRKII in both WT and Bax-/-Bak-/- 
MEFs upon BFA treatment (Fig. 4c), indicating that their cleavage occurs upstream of the 
mitochondrial apoptotic pathway. Furthermore, the loss of full-length CRKI and CRKII 
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occurs only when the level of ER stress rises to cytotoxic levels, and correlates with the 
initiation of ER stress-induced apoptosis (Supplementary Fig. S4)25-28.
In an attempt to determine the role of CRK cleavage for its apoptotic activity, we tested a 
small panel of protease inhibitors for their ability to block this event (data not shown). We 
found that the pan-cysteine protease inhibitor ZVAD-FMK prevents ER stress-induced loss 
of full-length CRKI and CRKII and protects Bax-/-Bak-/- MEFs from the cytopathic effects 
of ER stress (Supplementary Fig. S5). We previously identified caspase-2 as a pre-
mitochondrial cysteine protease activated by ER stress10. However, caspase-2 is poorly 
inhibited by ZVAD-FMK and in vitro experiments with recombinant caspase-2 do not result 
in CRK cleavage (data not shown). These data suggest that a previously unidentified ER 
stress-activated cysteine protease is responsible for CRK cleavage.
To determine if the observed ER stress-induced cleavage of CRK is critical for its apoptotic 
activity, we individually mutated each potential cysteine protease cleavage site (aspartic 
acid) in the CRK sequence. When stably reconstituted into crk-/- MEFs, CRKII ΔD110A 
(crk-/- +crkII (ΔD110A)) was the only aspartic acid mutant unable to be cleaved in response 
to ER stress (Fig. 4d). Furthermore, non-cleavable CRKII ΔD110A is defective in restoring 
crk-/- MEF sensitivity to ER stress-induced apoptosis (Fig. 4e, f), arguing that this cleavage 
event is critical for its apoptotic activity. Cleavage at D110 is predicted to produce one 
fragment of approximately 25kD, which can be detected by a C-terminal-specific antibody 
(Fig 4d), and a second N-terminal fragment of ~14kD, which is undetectable using available 
antibodies. As both CRKI and CRKII restore crk-/- sensitivity to ER stress, it is likely the 
shared N-terminal fragment (~14kd) contains the critical domain for its apoptotic function. 
To test this prediction, we transiently expressed the N-terminally FLAG-tagged fragment 
(NF110) in the absence of ER stress (Fig. 4g) and measured apoptosis. As predicted, NF110 
is able to potently induce cell death independently of ER stress (Fig. 4h, i). From these data, 
we conclude that CRK is cleaved upon ER stress at D110, to produce a pro-apoptotic 
fragment. Further studies will be necessary to identify the upstream protease and its 
connection to the unfolded protein response pathway.
To further investigate the mechanism by which CRK triggers cell death, we tested if CRK-
induced apoptosis is a BAX/BAK-dependent process. Transient overexpression of CRKI or 
CRKII triggers apoptosis in WT MEFs, but not Bax-/-Bak-/- MEFs, confirming that both 
isoforms signal upstream of the BAX/BAK-dependent mitochondrial apoptotic pathway 
(Fig. 5a-d). Pro-apoptotic BH3-only proteins are the only known molecules capable of 
activating BAX and/or BAK either directly or by inhibiting anti-apoptotic BCL-2 family 
proteins4,13. Through sequence analysis, we identified a putative BH3-like domain within 
CRK that contains a number of conserved amino acids present in several recognized BH3-
only proteins (Fig. 5e). This sequence is present in both crk splice forms and located within 
the common N-terminal 110 a.a. pro-apoptotic fragment (Fig. 1d, 5e). In support of our 
hypothesis that CRK contains a BH3-like domain, we determined that CRK is capable of 
binding a prototypical anti-apoptotic BCL-2 family protein (BCL-XL), a common feature of 
most BH3-only proteins. Following ER stress induction, transiently expressed FLAG-CRKII 
co-immunoprecipitates with BCL-XL on FLAG-specific agarose beads (Fig. 5f).
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To determine if this sequence has BH3-like pro-apoptotic activity, we treated isolated Jurkat 
mitochondria with a synthetic CRK BH3 domain (77-96 a.a.) and measured cytochrome c 
release. There are two classes of BH3-only domains, those that sensitize or activate BAX/
BAK-dependent mitochondrial apoptosis29. BH3 domains that directly “activate” BAX 
and/or BAK at mitochondria, such as the BH3 domain of BID, are able to cause cytochrome 
c release from isolated mitochondria. In contrast, “sensitizing” BH3 domains, such as the 
BH3 domains of BAD and BIK, sensitize isolated mitochondria to release cytochrome c in 
the presence of a second “activating” BH3 domain. In vivo, sensitizer BH3-only proteins are 
thought to competitively bind anti-apoptotic proteins, releasing bound “activating” BH3-
only proteins to induce mitochondrial permeability. While the CRK BH3 domain is unable 
to induce cytochrome c release alone, it significantly potentiates with low concentrations of 
truncated BID (tBID) to cause cytochrome c release (Fig. 5g).
To further examine if this putative BH3 domain is required for CRK's pro-apoptotic activity 
in cells, we mutated the highly conserved aspartic acid (D91A) in crkII and evaluated the 
ability of this mutant to rescue the crk-/- MEF phenotype. In comparison to wild-type crk, 
the BH3 mutant crk (D91A) has significantly decreased apoptotic activity, arguing that this 
region is critical for its pro-death signaling (Fig. 5h, i).
Together, these results identify CRK as a major pro-apoptotic signal required for the 
execution of ER stress-induced cell death. During ER stress, CRKI and CRKII are cleaved 
by a yet to be identified cysteine protease to generate an N-terminal fragment with potent 
apoptotic activity. Furthermore, CRK interacts with anti-apoptotic BCL-XL and its 
apoptotic activity is upstream of the BAX/BAK-dependent mitochondrial pathway. Both 
CRK isoforms contain a putative BH3 domain, which sensitizes isolated mitochondria to 
tBID-induced cytochrome c release and when mutated diminishes apoptotic activity in cells. 
These data argue that CRK is a previously unidentified BH3-only-like protein, which upon 
ER stress is proteolytically processed into a pro-death signal. Our findings suggest that CRK 
may be a valuable therapeutic target in diseases where ER stress-induced cell loss is 
implicated, including some forms of neurodegeneration and diabetes1,2.
We have identified a previously unknown pro-apoptotic function common to both CRK 
isoforms. CRK was initially identified through its homology with transforming v-crk7,30,31. 
However, only CRKI has been shown to have transforming activity in some cell culture 
models, and it is upregulated in a number of human cancers32,33. Clues that CRK mediates 
apoptosis are present in other species. For example, the C. elegans Crk-homologue CED-2 
regulates apoptotic engulfment34,35. Mammalian CRKII has been reported to induce death in 
some transformed cell types upon overexpression36,37 and is required for apoptotic activity 
that can be detected in Xenopus egg extracts38-40. Our work is the first to connect CRK to 
apoptosis, specifically under ER stress, in mammalian cells.
In addition to the shared pro-apoptotic function we have discovered for CRKI and CRKII, 
there are notable and possibly functionally significant differences between the isoforms. Our 
inability to establish a cell line stably overexpressing CRKI, in contrast to multiple cell lines 
stably overexpressing CRKII, suggests that CRKI may be the more cytotoxic isoform. 
Indeed, the expression of endogenous CRKI is restricted to approximately 10% that of 
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CRKII (Supplementary Fig. S1), perhaps to limit its toxicity. In support of this notion, we 
observe that CRKI is cleaved more efficiently and at earlier kinetics than CRKII in response 
to ER stress (Fig. 4c and Supplementary Fig. S4). These observations and our discovery that 
CRKI can be converted into a pro-apoptotic protein in response to ER stress raise the 
possibility that pharmacologic inducers of ER stress may have therapeutic efficacy in 
cancers where crkI is upregulated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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MATERIALS AND METHODS
Cellular Fractionation and Cytochrome c Release Assay
MEFS were resuspended in mitochondria isolation buffer (200mM sucrose, 10mM Tris/
MOPS (morpholinepropanesulfonic acid) [pH 7.4], 1mM EGTA) plus 1x protease inhibitor 
cocktail (PIC, Sigma) and manually disrupted by shearing the suspension 10x through a 27-
gauge and then 10x through a 30-gauge needle. Mitochondria (heavy membrane) were 
isolated from the suspension with an initial 700×g 4°C centrifugation to remove nuclei, 
followed by a 7000×g 4°C centrifugation to isolate heavy membrane (mitochondrial) 
fraction. The endoplasmic reticulum (light membrane) was isolated from the cytosolic 
fraction (S100) by a 100,000×g 4°C centrifugation. Mitochondrial and ER fractions were 
resuspended in RIPA (150mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, 50mM Tris [pH 
8.0]). S100 was dialyzed for 2 hours into 10% glycerol-containing mitochondria 
experimental buffer (MEB; 125mM KCl, 10mM Tris/MOPS [pH 7.4], 5mM glutamate, 
1.25mM malate, 2μM EGTA, 1μM KPhos). Jurkat mitochondria for the cytochrome c 
releasing assay were isolated as described above, minus the second shearing through the 30-
gauge needle. For the cytochrome c releasing assay reaction, 100-200μg (sample dependent) 
of S100 extract was incubated with 50μg of isolated Jurkat mitochondria for 45 minutes at 
room temperature. Following the incubation, the supernatant and pellet were separated by a 
4°C 16,000×g centrifugation. The remaining cytochrome c was released from mitochondria 
by resuspending the pellet in PBS plus 0.05% Triton-X. The amount of cytochrome c 
present in the supernatant and lysed pellets was quantified using a human cytochrome c 
linked immunosorbent assay (ELISA)(R&D systems) per the manufacturer's instructions. 
The percentage of cytochrome c release was calculated by dividing the amount of 
cytochrome c present in the supernatant by the sum of cytochrome c present in both the 
supernatant and pellet fractions.
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Purification of Cytochrome c Releasing Activity
The ER stress apoptotic factor was purified using the CcRA assay described above utilizing 
an AKTA FPLC (GE Healthcare). Briefly, 804mg of S100 protein isolated from 24h BFA 
(2.5 μg/ml) treated Bax-/-Bak-/- MEFs was initially precipitated with 40-80% saturated 
ammonium sulfate. This active fraction was then further purified on a Phenyl Sepharose 
column (GE Healthcare) by loading in 1M Ammonium Sulfate and eluting with a 100mM 
Na2HPO4 – 100mM Na2HPO4 gradient. The CcRA eluted in the 100.925-62.875ms/cm 
range and was further purified on a MonoP column (GE Healthcare) gradient pH 6-10. The 
CcRA eluted between pH 9-6. This fraction was then purified further on the Superdex 200 
column (GE Healthcare) and eluted in the 10-44kD range. This CcRA containing-fraction 
was run over a MonoQ column (GE Healthcare) 10mM KCl-1M KCl gradient. The purified 
CcRA fraction was analyzed in-gel and in-solution by MS-MS mass spectrometry by the 
UCSF Biomolecule Core Facility and the Stanford University of Medicine, Protein and 
Nucleic Acid Facility (PAN).
Cell culture and biological reagents
SV40 transformed Bax-/-Bak-/- and WT control MEFs were passaged as previously 
described17. Crk-/- and WT control MEFs were 3T3 immortalized. All MEFs were 
maintained in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine 
serum, 100U/ml penicillin, 100ug/ml streptomycin, 2mM glutamine, and nonessential amino 
acids (UCSF cell culture facility). Human Jurkat cells were maintained in RPMI 
supplemented with 10% fetal bovine serum, 100U/ml penicillin, 100ug/ml streptomycin, 
2mM glutamine, 100mM HEPES, and nonessential amino acids (UCSF cell culture facility). 
Annexin-V FITC was purchased from BioVision. Protease inhibitor cocktail (PIC), IPTG 
(isopropyl-4-D-thiogalactopyranoside), thapsigargin (TG), brefeldin A (BFA), staurosporine 
(STS), tunicamycin (TUN), and ZVAD-FMK were purchased from Sigma.
Antibodies and Western Blot analysis
Antibodies used for Western Blot analysis include anti-CRKII (Sigma)(1:1000), anti-CRK 
(BD Biosciences)(1:1000), anti-Mn SOD (assay designs)(1:500), anti-SERCA (affinity 
bioreagents)(1:1000), anti-BCL-XL (santa cruz technologies)(1:500), anti-FLAG M2 
(Sigma)(1:1000) and anti-ACTIN (Sigma)(1:1000). Secondary antibodies were purchased 
from Jackson ImmunoResearch (anti mouse, anti-rat, and anti-rabbit antibodies) and Bio-
Rad (anti-goat antibody)(1:2000).
Transient transfection and stable cell line selection
MEFs were transiently transfected using Lipofectamine 2000 (Invitrogen) per the 
manufacturer's instructions. 293 cells were transfected using Fugene6 (Promega) per the 
manufacturer's instructions. The crkI and crkII stable cell lines were made by transfecting a 
retroviral packaging line (293GPG or Phoenix) with pmx-crkI, pmx-crkII, and plpcx-crkII 
plasmids. Virus was harvested and titered from the supernatants of these packaging cell 
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lines. Following infection with the virus, stable lines were isolated using 1.25μg/ml 
puromycin selection.
Plasmid Construction
C-terminal FLAG-crkII was cloned using the following primers: 5’-
TTTGGATCCCGCCACCATGGCGGGCAACTTCGACTCGGAGGAG, 3’-
AAAGCGGCCGCTCACTTGTCATCGTCGTCCTTGTAGTCGCTGAAGTCCTCATCGG 
G. Crk aspartic acid mutants were generated using Stratagene Quickchange Lightning Site-
directed Mutagenesis Kit and the following primers; D39A (5’-
GGTGTTCCTGGTGCGGGCCTCGAGCACCAGCCCCG, 3’-
CGGGGCTGGTGCTCGAGGCCCGCACCAGGAACACC), D46A (5’-
GAGCACCAGCCCCGGGGCCTATGTGCTTAGCG, 3’-
CGCTAAGCACATAGGCCCCGGGGCTGGTGCTC), D110A (5’-
CACTATTTGGCCACTACAACATTGATAGAACCAGTGGCC, 3’-
GGCCACTGGTTCTATCAATGTTGTAGTGGCCAAATAGTG), D142A (5’-
TGTCGGGCCCTCTTTGCCTTTATAGGGAATGATG, 3’-
TCATTCCCATTAAAGGCAAAGAGGGCCCGCACA), D150A (5’-
GGGAATGATGAAGAAGCTCTTCCCTTTAAGAAAGGAGAC, 3’-
GTCTCCTTTCTTAAAGGGAAGAGCTTCTTCATCATTCCC), D157A (5’-
CCCTTTAAGAAAGGAGCCATCCTGAGAATCCGGG, 3’-
CCCGGATTCTCAGGATGGCTCCTTTCTTAAAGGG), D163A (5’-
CCTGAGAATCCGGGCTAAGCCTGAAGAGCAGTGGTGG, 3‘-
CCACCACTGCTCTTCAGGCTTAGCCCGGATTCTCAGG), D174A (5’-
GTGGTGGAATGCAGAGGCCAGCGAAGGAAAGAGGG, 3’-
CCCTCTTTCCTTCGCTGGCCTCTGCATTCCACCAC), D252A (5’-
GCGAGTCCCTAATGCCTACGCCAAGACAGCCTTGGC, 3’-
GCCAAGGCTGTCTTGGCGTAGGCATTAGGGACTCGC). N-terminal FLAG-tagged 
crk (110 a.a.) was cloned using 5’-
CGGCCAAGCTTCGCCACCATGGACTACAAGGACGA and 3’-
GGCCGGCGGCCGCTCAGTCCAAATAGTGTATTTTGTAG. Crk BH3 mutant was 
generated using Stratagene Quickchange Lightning Site-directed Mutagenesis Kit and these 
primers; 5’-CCCTCCAGGCTCCGAATAGCAGATCAAGAATTTGA, 3’-
TCAAATTCTTGATCTGCTATTCGGAGCCTGGAGGG.
qPCR
Crk isoform mRNA levels were quantitated using qpCR. Sybrgreen (applied biosystems) 
was used to measure crk isoforms with primers designed to recognize only crkII (primer 
sequence: 5’-ATGGCGGGCAACTTCGACT, 3’-CATCGGGATTCTGTTGATCC). The 
amount of crkII mRNA was subtracted from total crk mRNA (primer sequence: 3’-
CCCTCCTGGTTACCTCCAAT) in order to quantitate the amount of crkI mRNA present.
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Annexin V staining and FACS analysis
Cells were harvested with 0.25% trypsin, washed once with 1x PBS, and incubated with 
Annexin V binding buffer (2 mM CaCl2, 80 mM NaCl, 1% HEPES plus 1μg/ml fluorescein 
isothiocyanate-annexin V) for 5 min. The cells were subsequently passed through a 
FACSCalibur machine (Becton Dickinson) and detected with CellQuest software (BD 
Biosciences). Statistical analyses were completed using Student's t test.
Immunoprecipitation
Approximately 2.5 × 104 293 cells were transiently transfected using Fugene (Roche) per 
manufacturer's protocol for 24h with 2μg of plasmid encoding crkII wild-type or N-terminal 
Flag-tagged crkII. These cells were then treated with 1.25μg/ml BFA for 12h. Cells were 
then trypsinized, lysed in RIPA (50mM Tris, 150mM NaCl, 0.1% SDS, 0.5% Sodium 
Deoxycholate, 1% Triton X 100), and 200μg of whole cell lysate was incubated for 2h with 
anti-FLAG M2 affinity gel beads (SIGMA). The FLAG affinity beads were pelleted by 
centrifugation at 1200rpm for 5 minutes. The reaction supernatant was removed and 
concentrated using microcon centrifugal filter devices (3,000 MWCO)(amicon). The beads 
were washed four times in 1x phosphate buffered saline. SDS-containing loading dye was 
added to both the concentrated supernatant and the beads. Samples were boiled for 8 
minutes and run on a 10% Bis-Tris gel (Invitrogen). The transferred gel was immunoblotted 
for endogenous BCL-XL using anti-BCL-XL (santa cruz technologies)(1:500) and anti-
FLAG M2 (Sigma)(1:1000).
CRK synthetic peptide
The CRK BH3 domain peptide was synthesized by ELIM biopharm. Sequence synthesized: 
QPPPGVSPSRLRIGAQEFDS.
BH3 mitochondria sensitization assay
Jurkat mitochondria were isolated as described above and resuspended in MEB. The 
indicated dilutions of recombinant truncated BID (tBID) and 100μM CRK BH3 domain 
peptide were incubated with 50μg of isolated Jurkat mitochondria for 45 minutes at room 
temperature. Following the incubation, the supernatant and pellet were separated by a 4°C 
16,000×g centrifugation. The remaining cytochrome c was released from mitochondria by 
resuspending the pellet in PBS plus 0.05% Triton-X. The amount of cytochrome c present in 
the supernatant and lysed pellets was quantified using a human cytochrome c linked 
immunosorbent assay (ELISA)(R&D systems) per the manufacturer's instructions. The 
percentage of cytochrome c release was calculated by dividing the amount of cytochrome c 
present in the supernatant by the sum of cytochrome c present in both the supernatant and 
pellet fractions.
Statistical Analysis
Unpaired two-tailed Student's t-test was used to analyze flow cytometric and ELISA sample 
data.
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Figure 1. Biochemical purification of ER stress apoptotic activity identifies proto-oncogene 
CT-10-regulated kinase (CRK)
(a) Induction of cytochrome c release from isolated Jurkat mitochondria by cytosolic 
extracts (S100) from untreated (UNT) and 24h Brefeldin A (BFA) 2.5 μg/ml treated 
Bax-/-Bak-/- MEFs. (b) FPLC purification scheme of cytochrome c releasing activity (CcRA) 
present in BFA Bax-/-Bak-/- S100. Active fractions from each purification step are indicated. 
(c) CcRA assay of the fractions from the final step of the purification (MonoQ ion exchange 
gradient). (d) Diagram of CRK isoforms, domains, and amino acid sequence.
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Figure 2. Crk-/- MEFs are significantly resistant to ER stress-induced apoptosis
(a, b) 18h BFA (2.5 μg/ml)-treated crk-/- MEF S100 contains significantly less CcRA in 
comparison to 18h BFA-treated (2.5 μg/ml) wild-type MEF S100. n=3, error bars = sd. (c) 
crk-/- MEFs are visually resistant (phase contrast) to ER stress-induced apoptosis (BFA 
2.5μg/ml). Scale bar, 100μm. (d) crk-/- MEFs are strongly resistant to BFA and TUN-
induced apoptosis, but equally sensitive to staurosporine (STS), in comparison to wild-type 
MEFs. n=3, error bars = sd.
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Figure 3. CRKI or CRKII restores sensitivity of crk-/- MEFs to ER stress-induced apoptosis
(a, b) Transient expression of CRKI or CRKII sensitizes crk-/- MEFs to BFA-induced 
apoptosis. n=3, error bars = sd. (c-e) Stable CRKII expression in crk-/- MEFs rescues 
sensitivity to 24h BFA- and 18h TUN-induced apoptosis, but does not change sensitivity to 
STS-induced apoptosis. n=3, error bars = sd. Scale bar, 100μm. (f, g) Stable overexpression 
of CRKII in wild-type MEFs further increases sensitivity to 18h BFA-induced apoptosis. 
n=3, error bars = sd. (h, i) Transient overexpression of CRKI sensitizes WT MEFs to 18h 
BFA (1.25 μg/ml)-induced apoptosis. n=3, error bars = sd.
Austgen et al. Page 14
Nat Cell Biol. Author manuscript; available in PMC 2012 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 4. CRK is proteolytically cleaved into an apoptotic signal upon irremediable ER stress
(a) Upon 24h BFA (2.5 μg/ml) treatment of Bax-/-Bak-/- MEFs, full-length CRKII is 
depleted in the cytosol and at the ER. CRKII-specific fragments (*) appear in the cytosol, 
ER, and mitochondria. (b) Transiently expressed CRKI is also cleaved upon 24h BFA (2.5 
μg/ml) treatment in crk-/- MEFs. * = CRKI-specific fragment. (c) Loss of full-length, 
endogenous CRKI and CRKII observed upon 18h BFA treatment of WT and Bax-/-Bak-/- 
MEFs. (d) Upon ER stress, CRK is cleaved at D110. Mutation of this site (D110A) in 
CRKII prevents cleavage following 24h 2.5 μg/ml BFA treatment in stably reconstituted in 
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crk-/- MEFs. (e, f) CrkII (D110A) is not able to rescue crk-/- MEF sensitivity to ER stress-
induced apoptosis induced by 24h 2.5 μg/ml BFA, in contrast to crk-/- MEFs stably 
expressing wild-type (WT) CRKII. n=3, error bars = sd. (g) Diagram of CRK (1-110a.a.) 
cleavage fragment (NF110) produced upon ER stress. (h, i) Transient expression of NF110 
induces apoptosis independent of ER stress. n=3, error bars = sd.
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Figure 5. CRKII contains a putative BH3 domain and triggers BAX/BAK-dependent apoptosis
(a, b) CRKII and empty vector (pmx) were transiently overexpressed in WT and Bax-/-Bak-/- 
MEFs using retroviral infection. 24h post retroviral infection cells were treated with BFA 
(2.5 μg/ml) for an additional 24h and analyzed for Annexin-V expression by flow cytometry. 
n=3, error bars = sd. (c, d) CRKI and empty vector (pmx) were transiently overexpressed in 
WT and Bax-/-Bak-/- MEFs. 24h post transfection cells were treated an additional 18h with 
BFA (2.5 μg/ml) and analyzed for Annexin-V expression by flow cytometry. n=3, error bars 
= sd. (e) The sequences of the putative BH3-only domain of CRK and the “BH3 domain” 
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point mutation D91A are aligned against BH3 domains of several known BH3-only proteins. 
(f) 293 cells were transiently transfected 24h with Flag-crkII or untagged crkII, then treated 
14h BFA (1.25μg/ml). Lysates were incubated with FLAG-specific agarose beads. Beads 
were immunoblotted for endogenous BCL-XL. (g) Cytochrome c release from isolated 
Jurkat mitochondria incubated with decreasing doses of tBID and CRK BH3 domain 
peptide. n=3, error bars = sd. (h, i) Stable reconstitution of D91A crkII into crk-/- MEFs is 
significantly less effective at restoring ER stress-induced apoptosis (24h BFA treatment) in 
comparison to expression of wild-type crkII. n=3, error bars = sd.
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